NO845250L - Pyridin-2-etere resp. pyridin-2-tioetere med en nitrogenholdig cykloalifatisk ring, samt fremgangsmaate til deres fremstilling - Google Patents

Pyridin-2-etere resp. pyridin-2-tioetere med en nitrogenholdig cykloalifatisk ring, samt fremgangsmaate til deres fremstilling

Info

Publication number
NO845250L
NO845250L NO845250A NO845250A NO845250L NO 845250 L NO845250 L NO 845250L NO 845250 A NO845250 A NO 845250A NO 845250 A NO845250 A NO 845250A NO 845250 L NO845250 L NO 845250L
Authority
NO
Norway
Prior art keywords
pyridin
tioeters
cycloalifatic
eter
resp
Prior art date
Application number
NO845250A
Other languages
English (en)
Other versions
NO164237B (no
NO164237C (no
Inventor
Gerhard Scheffler
Juergen Engel
Vladimir Jakovlev
Bernd Nickel
Klaus Thiemer
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of NO845250L publication Critical patent/NO845250L/no
Publication of NO164237B publication Critical patent/NO164237B/no
Publication of NO164237C publication Critical patent/NO164237C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO845250A 1983-12-28 1984-12-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring. NO164237C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3347276 1983-12-28

Publications (3)

Publication Number Publication Date
NO845250L true NO845250L (no) 1985-07-01
NO164237B NO164237B (no) 1990-06-05
NO164237C NO164237C (no) 1990-09-12

Family

ID=6218282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO845250A NO164237C (no) 1983-12-28 1984-12-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridin-2-etere henholdsvis pyridin-2-tioetere med en nitrogenholdig, cykloalifatisk ring.

Country Status (20)

Country Link
US (1) US4643995A (no)
EP (1) EP0149088B1 (no)
JP (1) JPS60169476A (no)
KR (1) KR870000354B1 (no)
CN (1) CN85101353A (no)
AT (1) ATE40131T1 (no)
AU (1) AU566560B2 (no)
DD (1) DD231354A5 (no)
DE (2) DE3443968A1 (no)
DK (1) DK613384A (no)
ES (1) ES8607014A1 (no)
FI (1) FI84062C (no)
GB (1) GB2152048B (no)
GR (1) GR82596B (no)
HU (1) HU194209B (no)
IL (1) IL73608A (no)
NO (1) NO164237C (no)
PT (1) PT79736B (no)
SU (1) SU1417796A3 (no)
ZA (1) ZA848275B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836994B (en) * 1982-09-30 1984-05-30 Robins Co Inc A H Fused aromatic oxazepinones and sulfur analogs thereof
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
US4853027A (en) * 1986-09-08 1989-08-01 E. I. Du Pont De Nemours And Company Phytotoxic 2-alkyl-5-(heterocyclic)-pyrrole-3,4-dicarboxylates
EP0287908A3 (de) * 1987-04-18 1989-12-27 ASTA Medica Aktiengesellschaft Neue stickstoffhaltige, cycloaliphatische Verbindungen mit einem Aminosäurerest sowie einem Pyridinrest
GB8718445D0 (en) * 1987-08-04 1987-09-09 Wyeth John & Brother Ltd Pyridyl-ethers
CA1307790C (en) * 1987-08-04 1992-09-22 Ian Anthony Cliffe Ethers
FR2655649B1 (fr) * 1989-12-12 1994-07-08 Adir Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
US5914328A (en) * 1992-10-09 1999-06-22 Abbott Laboratories Heterocyclic ether compounds useful in controlling neurotransmitter release
US5948793A (en) * 1992-10-09 1999-09-07 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
US6437138B1 (en) 1996-06-06 2002-08-20 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
US6133253A (en) * 1996-12-10 2000-10-17 Abbott Laboratories 3-Pyridyl enantiomers and their use as analgesics
ATE247104T1 (de) 1997-11-05 2003-08-15 Neurosearch As Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
PE20000728A1 (es) * 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
MXPA02002115A (es) * 1999-09-14 2002-10-31 Abbott Lab Compuestos de eter 3-pirrolidiniloxi-3'-piridilico, utiles para controlar la transmision sinaptica quimica. .
DE10000739A1 (de) * 2000-01-11 2001-07-12 Merck Patent Gmbh Piperidin- und Piperazinderivate
US6436916B1 (en) 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
WO2003062224A1 (en) 2002-01-17 2003-07-31 Eli Lilly And Company Aza-cyclic compounds as modulators of acetylcholine receptors
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
CN100368409C (zh) * 2003-06-24 2008-02-13 神经研究公司 8-氮杂双环[3.2.1]辛烷衍生物及其用于制备单胺神经递质再摄取抑制剂的用途
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
DK1756084T3 (da) * 2004-06-04 2009-03-23 Arena Pharm Inc Substituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser beslægtet dermed
AR049401A1 (es) 2004-06-18 2006-07-26 Novartis Ag Aza-biciclononanos
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US7413805B2 (en) * 2005-02-25 2008-08-19 Fry's Metals, Inc. Preparation of metallic particles for electrokinetic or electrostatic deposition
NZ565898A (en) * 2005-09-16 2010-07-30 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
CN102516241B (zh) 2006-05-19 2015-07-29 艾伯维巴哈马有限公司 Cns活性的稠合的双环杂环取代的氮杂双环烷烃衍生物
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
MY148544A (en) 2007-05-23 2013-04-30 Merck Sharp & Dohme Pyridyl piperidine orexin receptor antagonists
US8669272B2 (en) 2008-10-21 2014-03-11 Merck Sharp & Dohme Corp. 2,5-disubstituted piperidine orexin receptor antagonists
WO2010048013A1 (en) 2008-10-21 2010-04-29 Merck Sharp & Dohme Corp. 2,5-disubstituted morpholine orexin receptor antagonists
JP2012506377A (ja) * 2008-10-21 2012-03-15 メルク・シャープ・エンド・ドーム・コーポレイション 2,4−二置換フェニルカルボキサミド・オレキシン受容体アンタゴニスト
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ, インコーポレイテッド (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス
KR101871011B1 (ko) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료
AR088352A1 (es) 2011-10-19 2014-05-28 Merck Sharp & Dohme Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
UA126268C2 (uk) 2015-01-06 2022-09-14 Арена Фармасьютікалз, Інк. СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub>
EA201890096A1 (ru) 2015-06-22 2018-08-31 Арена Фармасьютикалз, Инк. КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630125A (no) *
GB1041342A (en) * 1962-03-27 1966-09-07 Degussa New pyridine derivatives
NL122313C (no) * 1963-07-11
US3308129A (en) * 1964-06-05 1967-03-07 Smith Kline French Lab 3-tropanyl esters of atropic and thioatropic acids
GB1306139A (no) * 1970-08-06 1973-02-07
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
FR2187317B2 (no) * 1972-06-07 1975-06-20 Hexachimie
US3946024A (en) * 1972-06-22 1976-03-23 Cassella Farbwerke Mainkur Ag 2-Hydrocarbyloxy-pyridine compounds
US3954782A (en) * 1972-06-22 1976-05-04 Cassella Farbwerke Mainkur Aktiengesellschaft 2,6-Hydrazino-3-pyridine carboxyamides
US3947463A (en) * 1972-06-22 1976-03-30 Cassella Farbwerke Mainkur Ag Certain 2-amino-nicotinonitrile derivatives
US3956294A (en) * 1972-06-22 1976-05-11 Cassella Farbwerke Mainkur Aktiengesellschaft Substituted pyridine compounds
US4061642A (en) * 1972-06-22 1977-12-06 Cassella Farbwerke Mainkur Ag 2,4,6-Trisubstituted-3-pyridine carboxamides
US3980659A (en) * 1972-06-22 1976-09-14 Cassella Farbwerke Mainkur Aktiengesellschaft Certain 6-amino-4-hydrocarbyl-nicotinamides
DE2549999A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Piperidin-derivate und verfahren zu ihrer herstellung
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
FR2459240A1 (fr) * 1979-06-21 1981-01-09 Cm Ind Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
DE3045688A1 (de) * 1980-12-04 1982-07-08 C.H. Boehringer Sohn, 6507 Ingelheim Neue 8-arylalkyl-3-phenyl-3-nortropanole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung
IT1190942B (it) * 1982-08-04 1988-02-24 Poli Ind Chimica Spa Composto ad attivita' analgesica ed antiinfiammatoria,suo procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
EP0149088A1 (de) 1985-07-24
AU3699684A (en) 1985-07-04
FI84062B (fi) 1991-06-28
FI84062C (fi) 1991-10-10
DE3476205D1 (en) 1989-02-23
DE3443968A1 (de) 1985-10-31
FI845126A0 (fi) 1984-12-27
GB2152048A (en) 1985-07-31
KR870000354B1 (ko) 1987-03-05
AU566560B2 (en) 1987-10-22
JPS60169476A (ja) 1985-09-02
FI845126L (fi) 1985-06-29
GB8432162D0 (en) 1985-01-30
ES539076A0 (es) 1986-05-16
DK613384A (da) 1985-06-29
KR850004755A (ko) 1985-07-27
PT79736A (de) 1985-01-01
CN85101353A (zh) 1986-10-15
DK613384D0 (da) 1984-12-20
IL73608A0 (en) 1985-02-28
NO164237B (no) 1990-06-05
GB2152048B (en) 1987-11-11
DD231354A5 (de) 1985-12-24
ATE40131T1 (de) 1989-02-15
SU1417796A3 (ru) 1988-08-15
GR82596B (en) 1985-04-29
PT79736B (de) 1986-12-30
EP0149088B1 (de) 1989-01-18
NO164237C (no) 1990-09-12
IL73608A (en) 1987-12-31
ZA848275B (en) 1985-08-28
HUT36115A (en) 1985-08-28
HU194209B (en) 1988-01-28
ES8607014A1 (es) 1986-05-16
US4643995A (en) 1987-02-17

Similar Documents

Publication Publication Date Title
NO845250L (no) Pyridin-2-etere resp. pyridin-2-tioetere med en nitrogenholdig cykloalifatisk ring, samt fremgangsmaate til deres fremstilling
FI893632A0 (fi) Foereningar.
FI961739A (fi) Amiinisuoloja klavulaanihapon valmistamiseksi
NO881164L (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
ATE86623T1 (de) 8-azabicyclo(3,2,1&gt;octan- und 9azabicyclo(3,3,1&gt;nonanderivate.
DK0506778T3 (da) Substituerede 4-phenyl-4-piperidincarboxamider med både lokal anæstetisk og analgetisk virkning samt fremgangsmåder til deres fremstilling
DK521685D0 (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK543084A (da) Substituerede 3-carbamoyl-1,4-dihydropyridin-forbindelser og saltederaf samt deres fremstilling og anvendelse
DK166210C (da) Krystallinske cephalosporin-hydrohalogenidsalte, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
GR3001691T3 (en) Novel crystalline salts of aryloxy-propanolamines, their preparation and their use
DK412985A (da) Prolinforbindelse og farmaceutisk praeparat indeholdende forbindelsen
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK163247C (da) Gonadolibeinderivater, farmaceutisk acceptable syreadditionssalte og complexer heraf samt en fremgangsmaade til fremstilling af disse og et farmaceutisk praeparat indeholdende disse
DK30586D0 (da) N-substituerede 2-chlor-7-fluor-10-piperzino-10,11-dihydrodibenzo(b,f)thiepiner, deres syreadditionssalte og fremgangsmaader til deres fremstilling
FI890173A (fi) Isoxazoler med nootropisk verkan.
NO303497B1 (no) Oksazolidin-derivater og farmas°ytisk akseptable salter derav, samt anti-hyperlipidemi-blanding inneholdende disse
LT2141B (lt) Indolizino dariniu arba ju farmaciskai tinkamu drusku gavimo budas
LT2140B (lt) Indolizino dariniu arba ju farmaciskai tinkamu drusku gavimo budas
NO872354L (no) Nytt legemiddelpreparat med kontrollert frigivelse av den aktive forbindelsen, en fremgangsmaate for fremstilling derav og anvendelse av det nye preparatet.
DK152384D0 (da) Fremgangsmaade til fremstilling af to enantiomere af gamma-glutamyl-taurin,den racemiske blanding og farmaceutisk anvendelige salte deraf